共查询到20条相似文献,搜索用时 15 毫秒
1.
Dragovich PS Blazel JK Ellis DA Han Q Kamran R Kissinger CR LeBrun LA Li LS Murphy DE Noble M Patel RA Ruebsam F Sergeeva MV Shah AM Showalter RE Tran CV Tsan M Webber SE Kirkovsky L Zhou Y 《Bioorganic & medicinal chemistry letters》2008,18(20):5635-5639
The synthesis of 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones bearing 6-amino substituents as potent inhibitors of the HCV RNA-dependent RNA polymerase (NS5B) is described. Several of these agents also display potent antiviral activity in cell culture experiments (EC(50)<0.10 microM). In vitro DMPK data (microsome t(1/2), Caco-2 P(app)) for many of the compounds are also disclosed, and a crystal structure of a representative inhibitor complexed with the NS5B protein is discussed. 相似文献
2.
Sergeeva MV Zhou Y Bartkowski DM Nolan TG Norris DA Okamoto E Kirkovsky L Kamran R Lebrun LA Tsan M Patel R Shah AM Lardy M Gobbi A Li LS Zhao J Bertolini T Stankovic N Sun Z Murphy DE Webber SE Dragovich PS 《Bioorganic & medicinal chemistry letters》2008,18(11):3421-3426
5-Hydroxy-3(2H)-pyridazinone derivatives were investigated as potent inhibitors of genotype 1 HCV NS5B polymerase focusing on the optimization of their drug metabolism and pharmacokinetics (DMPK) profiles. This investigation led to the discovery of potent inhibitors with improved DMPK properties. 相似文献
3.
Zhou Y Webber SE Murphy DE Li LS Dragovich PS Tran CV Sun Z Ruebsam F Shah AM Tsan M Showalter RE Patel R Li B Zhao Q Han Q Hermann T Kissinger CR Lebrun L Sergeeva MV Kirkovsky L 《Bioorganic & medicinal chemistry letters》2008,18(4):1413-1418
5-Hydroxy-3(2H)-pyridazinone derivatives were investigated as inhibitors of genotype 1 HCV NS5B polymerase. The synthesis, structure-activity relationships (SAR), metabolic stability, and structure-based design approach for this new class of compounds are discussed. 相似文献
4.
Li LS Zhou Y Murphy DE Stankovic N Zhao J Dragovich PS Bertolini T Sun Z Ayida B Tran CV Ruebsam F Webber SE Shah AM Tsan M Showalter RE Patel R Lebrun LA Bartkowski DM Nolan TG Norris DA Kamran R Brooks J Sergeeva MV Kirkovsky L Zhao Q Kissinger CR 《Bioorganic & medicinal chemistry letters》2008,18(11):3446-3455
5-Hydroxy-3(2H)-pyridazinone derivatives were investigated as inhibitors of genotype 1 HCV NS5B polymerase. Lead optimization led to the discovery of compound 3a, which displayed potent inhibitory activities in biochemical and replicon assays [IC(50) (1b)<10nM; IC(50) (1a)=22 nM; EC(50) (1b)=5nM], good stability toward human liver microsomes (HLM t(1/2)>60 min), and high ratios of liver to plasma concentrations 12h after a single oral administration to rats. 相似文献
5.
Ellis DA Blazel JK Webber SE Tran CV Dragovich PS Sun Z Ruebsam F McGuire HM Xiang AX Zhao J Li LS Zhou Y Han Q Kissinger CR Showalter RE Lardy M Shah AM Tsan M Patel R LeBrun LA Kamran R Bartkowski DM Nolan TG Norris DA Sergeeva MV Kirkovsky L 《Bioorganic & medicinal chemistry letters》2008,18(16):4628-4632
4-(1,1-Dioxo-1,4-dihydro-1lambda(6)-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-one analogs were discovered as a novel class of inhibitors of HCV NS5B polymerase. Structure-based design led to the identification of compound 3a that displayed potent inhibitory activities in biochemical and replicon assays (1b IC(50)<10 nM; 1b EC(50)=1.1 nM) as well as good stability toward human liver microsomes (HLM t(1/2)>60 min). 相似文献
6.
7.
To develop novel biologically active organic compounds possessing a sugar moiety, a series of 2-phenylsulfonylhydrazono-3-(2',3',4',6'-tetra-O-acetyl-beta-d-glucopyranosyl)thiazolidine-4-one were synthesized via reaction of the thiosemicarbazide with ethyl bromoacetate. Their chemical structures were characterized by (1)H and (13)C NMR spectroscopy, elemental analysis and MS. The bioassay results indicated that some of these compound exhibit moderate fungicidal and herbicidal activities. Furthermore, the effect of various solvents at reflux temperature on the reactions of ethyl bromoacetate with the related thiosemicarbazides was investigated. 相似文献
8.
Frank Ruebsam Chinh V. Tran Lian-Sheng Li Sun Hee Kim Alan X. Xiang Yuefen Zhou Julie K. Blazel Zhongxiang Sun Peter S. Dragovich Jingjing Zhao Helen M. McGuire Douglas E. Murphy Martin T. Tran Nebojsa Stankovic David A. Ellis Alberto Gobbi Richard E. Showalter Stephen E. Webber Amit M. Shah Mei Tsan Leo Kirkovsky 《Bioorganic & medicinal chemistry letters》2009,19(2):451-458
5,6-Dihydro-1H-pyridin-2-one analogs were discovered as a novel class of inhibitors of genotype 1 HCV NS5B polymerase. Among these, compound 4ad displayed potent inhibitory activities in biochemical and replicon assays (IC50 (1b) < 10 nM; IC50 (1a) < 25 nM, EC50 (1b) = 16 nM), good in vitro DMPK properties, as well as moderate oral bioavailability in monkeys (F = 24%). 相似文献
9.
10.
Du J Patterson S Shi J Chun BK Stuyver LJ Watanabe KA 《Bioorganic & medicinal chemistry letters》2004,14(5):1243-1245
Novel racemic 5'-C-methyl-1',3'-dioxolan-4'-yl nucleosides were synthesized from the key intermediate, 2-benzoyloxymethyl-4-oxo-5-C-methyl-1,3-dioxolane, which was prepared from racemic lactic acid. 相似文献
11.
The previously reported analog of pregnenolone having a 3,4-dihydro-2H-pyran attached via a Cz.sbnd;C bond to the C-20 position (1), stereoselectively reacts with m-chloroperoxybenzoic acid in methanol at -5 degrees C. Acid-catalyzed hydrolysis of the isolated intermediates gives good yields of mostly a new 27-norcholesterol analog: (20R,23R)-3,20,23,26-tetrahydroxy-27-norcholest-5-en-22-one-3-acetate (2a, and a smaller amount of its 23S enantiomer 2b). Three different conditions of epoxidation and methanolysis followed by acid-catalyzed hydrolysis typically produce approximately 2:1 ratios of the 23R:23S diastereoisomers with a C-23 hydroxy group at the new asymmetric center. Bromine also reacts stereoselectively with (20R)-3,20-dihydroxy-(3',4'-dihydro-2'H-pyranyl)-5-pregnene (4) giving mostly (20R,23R)-23-bromo-3,20,26-trihydroxy-27-norcholest-5-en-22-one (7a). Thus both major steroidal products 2a and 7a have the same C-23R configuration. Assignment of molecular structures and the absolute configurations to 1 and 2a were based on elemental analysis, mass spectra, nuclear magnetic resonance, FTIR infrared spectroscopic analysis and X-ray crystallography. Mechanisms are discussed for stereochemical selectivity during epoxidation and bromination of the 3,4-dihydro-2H-pyranyl ring in 1 and 4. 相似文献
12.
Rockway TW Zhang R Liu D Betebenner DA McDaniel KF Pratt JK Beno D Montgomery D Jiang WW Masse S Kati WM Middleton T Molla A Maring CJ Kempf DJ 《Bioorganic & medicinal chemistry letters》2006,16(14):3833-3838
A series of non-nucleoside HCV NS5B polymerase inhibitors based on the N-1-benzyl or N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine core substituted in the D-ring aromatic moiety have been prepared and evaluated. Aromatic substituents extending from position 7 of the D-ring exhibited excellent potency against both genotypes 1a and 1b. 相似文献
13.
Pfefferkorn JA Greene ML Nugent RA Gross RJ Mitchell MA Finzel BC Harris MS Wells PA Shelly JA Anstadt RA Kilkuskie RE Kopta LA Schwende FJ 《Bioorganic & medicinal chemistry letters》2005,15(10):2481-2486
A novel series of nonnucleoside HCV NS5B polymerase inhibitors were prepared from (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid, a high throughput screening lead. SAR studies combined with structure based drug design focusing on the southern heterobiaryl region of the template led to the synthesis of several potent and orally bioavailable lead compounds. X-ray crystallography studies were also performed to understand the interaction of these inhibitors with HCV NS5B polymerase. 相似文献
14.
Barbara Pacini Salvatore Avolio Caterina Ercolani Uwe Koch Giovanni Migliaccio Frank Narjes Laura Pacini Licia Tomei Steven Harper 《Bioorganic & medicinal chemistry letters》2009,19(21):6245-6249
A series of 2-(3-thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acid inhibitors of the hepatitis C virus (HCV) NS5B polymerase enzyme are reported. Sulfonyl urea substituted analogs in this series proved to be the most potent active site non-nucleoside inhibitors of NS5B reported to date. These compounds had low nanomolar enzyme inhibition across HCV genotypes 1–3 and showed single digit micromolar inhibition in the HCV replicon assay. This improved cell-based activity allowed the binding mode of these compounds to be probed by selection of resistant mutations against compound 21. The results generated are in broad agreement with the previously proposed binding model for this compound class. 相似文献
15.
Enzymatic and chemical preparation of 5-amino-4-chloro-2-(2,3-dihydroxyphen-1-yl)-3(2H)-pyridazinone
Siegfried Haug Jürgen Eberspächer Franz Lingens 《Biochemical and biophysical research communications》1973,54(2):760-763
A hypothetical intermediate of the microbial degradation of pyrazon, 5-amino-4-chloro-2(2,3-dihydroxyphen-1-yl)-3(2H)-pyridazinone, was prepared by enzymatic and chemical treatment of 5-amino-4-chloro-2(2,3-dihydroxy-cyclohexa-4,6-dien-1-yl)-pyridazinone. The properties of the metabolite are described. 相似文献
16.
Pfefferkorn JA Nugent R Gross RJ Greene M Mitchell MA Reding MT Funk LA Anderson R Wells PA Shelly JA Anstadt R Finzel BC Harris MS Kilkuskie RE Kopta LA Schwende FJ 《Bioorganic & medicinal chemistry letters》2005,15(11):2812-2818
A novel series of non-nucleoside HCV NS5B polymerase inhibitors was prepared from a (2Z)-2-benzoylamino-3-(4-phenoxy-phenyl)-acrylic acid template. Solution and solid phase analog synthesis focused on the northern region of the template combined with structure based design led to the discovery of several potent and orally bioavailable lead compounds. 相似文献
17.
Okazaki R Oritani T Hara Y Yamamoto H 《Bioscience, biotechnology, and biochemistry》2001,65(4):943-946
Microbial hydroxylation of (+/-)-(2Z,4E)-5-(1',2'-epoxy-2',6',6'-trimethylcyclohexyl)-3-methyl-2,4-pentadienoic acid (3a) with Cercospora cruenta, a fungus producing (+)-abscisic acid, gave a four-stereoisomeric mixture consisting of (+)- and (-)-xanthoxin acid (4a), and (+)- and (-)-epi-xanthoxin acid (5a) by an HPLC analysis with a chiral column. Screening of the microorganisms capable of oxidizing (+/-)-3a showed that Cunninghamella echinulata stereoselectively oxidized (+/-)-3a to xanthoxin acid (4a) with the some degree of enantioselectivity as (-)-3a to (-)-4a. 相似文献
18.
Rosanna Tedesco Deping Chai Michael G. Darcy Dashyant Dhanak Duke M. Fitch Adam Gates Victor K. Johnston Richard M. Keenan Juili Lin-Goerke Robert T. Sarisky Antony N. Shaw Klara L. Valko Kenneth J. Wiggall Michael N. Zimmerman Kevin J. Duffy 《Bioorganic & medicinal chemistry letters》2009,19(15):4354-4358
Modification of the benzo rings of 3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones into heteroaromatic systems was investigated to enhance physicochemical properties and potency profile of this class of inhibitors. The synthesis and biological activity of the derived compounds is discussed. 相似文献
19.
20.
N-Chloroacetyl-5-bromoanthranilic acid (1), 3-[4'-(p-chlorophenyl)-thiazol-2'-yl]-2-chloromethyl-6-bromoquinazolin-4-one (2), 3-[4'-(p-chlorophenyl)-thiazol-2'-yl]-2-hydrazinomethyl-6-bromoquinazolin-4-one (3), 3-[4'-(p-chlorophenyl)-thiazol-2'-yl]-2-substitutedbenzylidene aminomethyl-6-bromoquinazolin-4-ones (4-11), 2-[(4'-oxo-3'-chloro-2'-phenylazetidin-1'-yl)aminomethyl]-3-[4'-(p-chlorophenyl)thiazol-2'-yl]-6-bromoquinazolin-4-ones (12-19) and 2-(4'-oxo-2'-phenyl-thiazolidin-3'-yl-aminomethyl)- 3-[4'-(p-chlorophenyl)-thiazol-2'-yl]-6-bromoquinazolin-4-ones (20-27) have been synthesized. All the compounds have been screened for their anti-inflammatory and analgesic activities at the dose of 50mg/kg po. Compound 21 showed maximum anti-inflammatory (38.35%) and analgesic (37.36%) activities. Compound 21 was also tested for ulcerogenic activity and the UD(50) value was found to be 195.6mg/kg po. The structure of all compounds has been evaluated by elemental analysis (C, H, N) and spectral analysis (IR, (1)H NMR and mass spectrometry). 相似文献